Metabolic Signaling Research
AOD-9604 + MOTS-c Stack — Non-GLP-1 Metabolic Peptide Stack
A lower-cost metabolic option without a GLP-1, pairing fat-metabolism and mitochondrial signaling research.
Total program: 12 weeks · 2 individual vials
Why these peptides are researched together
A metabolic pairing without any GLP-1. AOD-9604 is studied for fat breakdown at the fat cell, while MOTS-c is studied in AMPK energy-sensing and insulin-sensitivity signaling in muscle. One pathway acts on stored fat, the other on how cells use energy.
Each peptide at a glance
- AOD-9604: Modified hGH fragment 176–191 studied in lipolysis models.
- MOTS-c: Mitochondrial-derived peptide studied in AMPK and insulin-sensitivity models.
How the schedules fit together
The total program is 12 weeks. AOD-9604 is drawn once daily for all 12 weeks. MOTS-c runs two 20-day courses (every 5 days, 4 administrations each): Course 1 in Weeks 1–3 (program Days 1–20), then 4 weeks off, then Course 2 in Weeks 8–10 (program Days 50–69), both inside the AOD-9604 window.
What the research shows
MOTS-c has preclinical metabolic research; AOD-9604 has early human safety data.
Still unproven
No study has tested the pairing.
FAQs
What is the AOD-9604 + MOTS-c Stack?
A lower-cost metabolic option without a GLP-1, pairing fat-metabolism and mitochondrial signaling research.
What's in the AOD-9604 + MOTS-c Stack?
The AOD-9604 + MOTS-c Stack combines AOD-9604 and MOTS-c, each in its own vial. AOD-9604: Modified hGH fragment 176–191 studied in lipolysis models. MOTS-c: Mitochondrial-derived peptide studied in AMPK and insulin-sensitivity models.
What does the AOD-9604 + MOTS-c Stack do?
A metabolic pairing without any GLP-1. AOD-9604 is studied for fat breakdown at the fat cell, while MOTS-c is studied in AMPK energy-sensing and insulin-sensitivity signaling in muscle. One pathway acts on stored fat, the other on how cells use energy.
What is the AOD-9604 + MOTS-c Stack dosage?
The amounts for each peptide are listed week by week in the dosing table on this page, taken from each peptide's full dosing chart, with units on a 100-unit syringe and exact vial counts for the full 12-week program.
How long is the AOD-9604 + MOTS-c Stack?
The AOD-9604 + MOTS-c Stack is laid out as a 12-week research program. The total program is 12 weeks. AOD-9604 is drawn once daily for all 12 weeks. MOTS-c runs two 20-day courses (every 5 days, 4 administrations each): Course 1 in Weeks 1–3 (program Days 1–20), then 4 weeks off, then Course 2 in Weeks 8–10 (program Days 50–69), both inside the AOD-9604 window.
What does research show about the AOD-9604 + MOTS-c Stack?
MOTS-c has preclinical metabolic research; AOD-9604 has early human safety data. Still unproven: No study has tested the pairing.
Sources
- Meto — The 7 Most Popular Peptide Stacks: What the Science Actually Says
- PubMed — MOTS-c metabolic research
- PubMed — AOD-9604 research
Other peptide stacks
- Wolverine Stack
- GLOW Peptide Stack
- KLOW Peptide Stack
- CJC-1295 + Ipamorelin Stack
- Tesamorelin + Ipamorelin Stack
- Semax + Selank + NAD+ Stack
- Mitochondrial Peptide Stack
- Tirzepatide + AOD-9604 Stack
- Epitalon + Pinealon Stack
Educational research reference only. Not medical advice or individualized guidance.